Johnson & Johnson Enterprise Value: 174.44B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
JNJ Enterprise Value Rankings
| Overall | 99th percentile | 24 of 4268 |
| Sector | 99th percentile | 2 of 500 in Healthcare |
| Industry | 92nd percentile | 2 of 25 in Drug Manufacturers - Major |
JNJ Enterprise Value Range, Past 5 Years
| Minimum | 40.97B | Mar 2001 |
| Maximum | 196.70B | Mar 2002 |
| Average | 158.39B |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
You may also be interested in these JNJ related companies
JNJ News
News related to $JNJ, currently-0.6 pct.: 'Stryker says President and CEO MacMillan resigned' http://stks.co/2Ko9
about 3 days ago by TradeBot
about 3 days ago by TradeBot
$JNJ ... swing long started this am is starting to work ... next add area is $65.39ish
about 4 days ago by Leaf_West
about 4 days ago by Leaf_West
$JNJ failed a test of resistance, nice little short opportunity here http://chart.ly/taubwgh
about 6 days ago by optionmaster
about 6 days ago by optionmaster
long $JNJ for dvd looking for break above long long resistance in high 60's. now if they can just avoid a bad news release!
about 6 days ago by Fundies
about 6 days ago by Fundies
$JNJ Insider Sale: $29.6M of stock sold by William Weldon (Director Chairman/ceo) on February 1, 2012 http://stks.co/2F43
about 9 days ago by MarketBrief
about 9 days ago by MarketBrief
@taketheplunge $VRTX That makes little sense to me. More likely a $JNJ BO of $VRTX I would think.
about 9 days ago by SCIGUY
about 9 days ago by SCIGUY
R&D in Quebec pharma industry continues to erode $AZN $JNJ $SNY $MRK
about 10 days ago by michaelbabad
about 10 days ago by michaelbabad
$JNJ Strong Trending 66.315 from 12/27/2011 Hold 5 Days 64% Success http://stks.co/2Bxh 9:33EST #tradeideas #investing #stocks
about 11 days ago by TradeIdeas1
about 11 days ago by TradeIdeas1
Morning News: January 31, 2012 | via @EddyElfenbein http://stks.co/2APO $JNJ $AAPL $RIM
about 13 days ago by STNet
about 13 days ago by STNet
I'd say it was pretty clear that McNeil wasn't anywhere near being on the right track. No-brainer move to change the management again. $JNJ
about 13 days ago by bradloncar
about 13 days ago by bradloncar
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| JNJ | 64.60 | -0.29 | -0.45% | 176.41B |
| EK | 0.36 | -0.19 | -35.10% | 96.86M |
| AEIS | 10.84 | 0.11 | 1.03% | 480.97M |
| CGA | 4.75 | 0.00 | 0.00% | 127.54M |
| FIG | 4.24 | -0.14 | -3.20% | 2.08B |
| TF | 9.69 | -0.08 | -0.82% | |
| TIVO | 11.96 | -0.22 | -1.81% | 1.44B |
| POT | 44.70 | -1.17 | -2.55% | 38.38B |
| WFC | 30.26 | -0.32 | -1.05% | 159.58B |
| HNP | 25.02 | 0.03 | 0.12% | 7.54B |
